Gregory Grunberg, Director at Kala Pharmaceuticals, Inc. (KALA), bought 2,270,946 shares at $15.00 ($3.2M) on 2017-07-25, disclosed to the SEC on 2017-07-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,055,946 | $0 | 0.0% |
| 2 | $15.00 | 215,000 | $3.2M | 100.0% |
| Total | $1.42 avg | 2,270,946 | $3.2M | 100% |
| Filing → |
| KALA | BUY | 2020-03-16 | $40.0M | — | Filing → |
| ETNB | BUY | 2019-11-13 | $9.2M | — | Filing → |
| KALA | BUY | 2018-10-09 | $5.0M | — | Filing → |